The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Dermal Filler Injections Market Research Report 2024

Global Dermal Filler Injections Market Research Report 2024

Publishing Date : Sep, 2023

License Type :
 

Report Code : 1796552

No of Pages : 104

Synopsis
Dermal filler injections are cosmetic procedures that involve the injection of gel-like substances into the skin to restore volume, smooth out wrinkles, and enhance facial contours. These fillers are primarily used for non-surgical facial rejuvenation and are a popular option for individuals seeking temporary results without the need for invasive surgery.
Global Dermal Filler Injections market is projected to reach US$ 8876 million in 2029, increasing from US$ 3797 million in 2022, with the CAGR of 12.9% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Dermal Filler Injections market research.
The global dermal filler injections market has experienced significant growth over the past decade and is expected to continue expanding. Factors contributing to this growth include the increasing demand for non-surgical cosmetic procedures, advancements in filler technology, growing awareness about facial aesthetics, and the desire for facial rejuvenation among aging populations. The market for dermal filler injections is global, with significant demand observed across various regions, including North America, Europe, Asia-Pacific, and other parts of the world. North America has traditionally held a prominent market share, driven by factors such as a large consumer base, advanced healthcare infrastructure, and high disposable incomes. However, the Asia-Pacific region, particularly China and South Korea, has been experiencing rapid growth due to increasing aesthetic consciousness and a growing middle-class population.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Dermal Filler Injections market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Allergan
Galderma
LG Life Sciences
Hugel
Medytox
Merz
Sinclair Pharma
Suneva Medical
Luminera
Teoxane
Bausch Health
Humedix
Sanofi
Croma-Pharma GmbH
BLOOMAGE BIOTECH
Anika Therapeutics
Segment by Type
Hyaluronic Acid (HA)
Calcium Hydroxylapatite (CaHA)
Poly-L-Lactic Acid (PLLA)
Polymethylmethacrylate (PMMA)
Segment by Application
Hospital
Beauty Parlour
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Dermal Filler Injections report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Dermal Filler Injections Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Hyaluronic Acid (HA)
1.2.3 Calcium Hydroxylapatite (CaHA)
1.2.4 Poly-L-Lactic Acid (PLLA)
1.2.5 Polymethylmethacrylate (PMMA)
1.3 Market by Application
1.3.1 Global Dermal Filler Injections Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Beauty Parlour
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Dermal Filler Injections Market Perspective (2018-2029)
2.2 Dermal Filler Injections Growth Trends by Region
2.2.1 Global Dermal Filler Injections Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Dermal Filler Injections Historic Market Size by Region (2018-2023)
2.2.3 Dermal Filler Injections Forecasted Market Size by Region (2024-2029)
2.3 Dermal Filler Injections Market Dynamics
2.3.1 Dermal Filler Injections Industry Trends
2.3.2 Dermal Filler Injections Market Drivers
2.3.3 Dermal Filler Injections Market Challenges
2.3.4 Dermal Filler Injections Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Dermal Filler Injections Players by Revenue
3.1.1 Global Top Dermal Filler Injections Players by Revenue (2018-2023)
3.1.2 Global Dermal Filler Injections Revenue Market Share by Players (2018-2023)
3.2 Global Dermal Filler Injections Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Dermal Filler Injections Revenue
3.4 Global Dermal Filler Injections Market Concentration Ratio
3.4.1 Global Dermal Filler Injections Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Dermal Filler Injections Revenue in 2022
3.5 Dermal Filler Injections Key Players Head office and Area Served
3.6 Key Players Dermal Filler Injections Product Solution and Service
3.7 Date of Enter into Dermal Filler Injections Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Dermal Filler Injections Breakdown Data by Type
4.1 Global Dermal Filler Injections Historic Market Size by Type (2018-2023)
4.2 Global Dermal Filler Injections Forecasted Market Size by Type (2024-2029)
5 Dermal Filler Injections Breakdown Data by Application
5.1 Global Dermal Filler Injections Historic Market Size by Application (2018-2023)
5.2 Global Dermal Filler Injections Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Dermal Filler Injections Market Size (2018-2029)
6.2 North America Dermal Filler Injections Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Dermal Filler Injections Market Size by Country (2018-2023)
6.4 North America Dermal Filler Injections Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Dermal Filler Injections Market Size (2018-2029)
7.2 Europe Dermal Filler Injections Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Dermal Filler Injections Market Size by Country (2018-2023)
7.4 Europe Dermal Filler Injections Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Dermal Filler Injections Market Size (2018-2029)
8.2 Asia-Pacific Dermal Filler Injections Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Dermal Filler Injections Market Size by Region (2018-2023)
8.4 Asia-Pacific Dermal Filler Injections Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Dermal Filler Injections Market Size (2018-2029)
9.2 Latin America Dermal Filler Injections Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Dermal Filler Injections Market Size by Country (2018-2023)
9.4 Latin America Dermal Filler Injections Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Dermal Filler Injections Market Size (2018-2029)
10.2 Middle East & Africa Dermal Filler Injections Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Dermal Filler Injections Market Size by Country (2018-2023)
10.4 Middle East & Africa Dermal Filler Injections Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Allergan
11.1.1 Allergan Company Detail
11.1.2 Allergan Business Overview
11.1.3 Allergan Dermal Filler Injections Introduction
11.1.4 Allergan Revenue in Dermal Filler Injections Business (2018-2023)
11.1.5 Allergan Recent Development
11.2 Galderma
11.2.1 Galderma Company Detail
11.2.2 Galderma Business Overview
11.2.3 Galderma Dermal Filler Injections Introduction
11.2.4 Galderma Revenue in Dermal Filler Injections Business (2018-2023)
11.2.5 Galderma Recent Development
11.3 LG Life Sciences
11.3.1 LG Life Sciences Company Detail
11.3.2 LG Life Sciences Business Overview
11.3.3 LG Life Sciences Dermal Filler Injections Introduction
11.3.4 LG Life Sciences Revenue in Dermal Filler Injections Business (2018-2023)
11.3.5 LG Life Sciences Recent Development
11.4 Hugel
11.4.1 Hugel Company Detail
11.4.2 Hugel Business Overview
11.4.3 Hugel Dermal Filler Injections Introduction
11.4.4 Hugel Revenue in Dermal Filler Injections Business (2018-2023)
11.4.5 Hugel Recent Development
11.5 Medytox
11.5.1 Medytox Company Detail
11.5.2 Medytox Business Overview
11.5.3 Medytox Dermal Filler Injections Introduction
11.5.4 Medytox Revenue in Dermal Filler Injections Business (2018-2023)
11.5.5 Medytox Recent Development
11.6 Merz
11.6.1 Merz Company Detail
11.6.2 Merz Business Overview
11.6.3 Merz Dermal Filler Injections Introduction
11.6.4 Merz Revenue in Dermal Filler Injections Business (2018-2023)
11.6.5 Merz Recent Development
11.7 Sinclair Pharma
11.7.1 Sinclair Pharma Company Detail
11.7.2 Sinclair Pharma Business Overview
11.7.3 Sinclair Pharma Dermal Filler Injections Introduction
11.7.4 Sinclair Pharma Revenue in Dermal Filler Injections Business (2018-2023)
11.7.5 Sinclair Pharma Recent Development
11.8 Suneva Medical
11.8.1 Suneva Medical Company Detail
11.8.2 Suneva Medical Business Overview
11.8.3 Suneva Medical Dermal Filler Injections Introduction
11.8.4 Suneva Medical Revenue in Dermal Filler Injections Business (2018-2023)
11.8.5 Suneva Medical Recent Development
11.9 Luminera
11.9.1 Luminera Company Detail
11.9.2 Luminera Business Overview
11.9.3 Luminera Dermal Filler Injections Introduction
11.9.4 Luminera Revenue in Dermal Filler Injections Business (2018-2023)
11.9.5 Luminera Recent Development
11.10 Teoxane
11.10.1 Teoxane Company Detail
11.10.2 Teoxane Business Overview
11.10.3 Teoxane Dermal Filler Injections Introduction
11.10.4 Teoxane Revenue in Dermal Filler Injections Business (2018-2023)
11.10.5 Teoxane Recent Development
11.11 Bausch Health
11.11.1 Bausch Health Company Detail
11.11.2 Bausch Health Business Overview
11.11.3 Bausch Health Dermal Filler Injections Introduction
11.11.4 Bausch Health Revenue in Dermal Filler Injections Business (2018-2023)
11.11.5 Bausch Health Recent Development
11.12 Humedix
11.12.1 Humedix Company Detail
11.12.2 Humedix Business Overview
11.12.3 Humedix Dermal Filler Injections Introduction
11.12.4 Humedix Revenue in Dermal Filler Injections Business (2018-2023)
11.12.5 Humedix Recent Development
11.13 Sanofi
11.13.1 Sanofi Company Detail
11.13.2 Sanofi Business Overview
11.13.3 Sanofi Dermal Filler Injections Introduction
11.13.4 Sanofi Revenue in Dermal Filler Injections Business (2018-2023)
11.13.5 Sanofi Recent Development
11.14 Croma-Pharma GmbH
11.14.1 Croma-Pharma GmbH Company Detail
11.14.2 Croma-Pharma GmbH Business Overview
11.14.3 Croma-Pharma GmbH Dermal Filler Injections Introduction
11.14.4 Croma-Pharma GmbH Revenue in Dermal Filler Injections Business (2018-2023)
11.14.5 Croma-Pharma GmbH Recent Development
11.15 BLOOMAGE BIOTECH
11.15.1 BLOOMAGE BIOTECH Company Detail
11.15.2 BLOOMAGE BIOTECH Business Overview
11.15.3 BLOOMAGE BIOTECH Dermal Filler Injections Introduction
11.15.4 BLOOMAGE BIOTECH Revenue in Dermal Filler Injections Business (2018-2023)
11.15.5 BLOOMAGE BIOTECH Recent Development
11.16 Anika Therapeutics
11.16.1 Anika Therapeutics Company Detail
11.16.2 Anika Therapeutics Business Overview
11.16.3 Anika Therapeutics Dermal Filler Injections Introduction
11.16.4 Anika Therapeutics Revenue in Dermal Filler Injections Business (2018-2023)
11.16.5 Anika Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’